Press Release | May 31, 2019 | Biotechnology Innovation Organization (BIO), BIO Announcements, Business & BIO Industry, Industry Analysis Reports, Capital Formation, Public Capital Formation, Private Capital Formation, Human Health, Drug Development Process, Drug Discovery, Phase 1, Phase 2, Phase 3
Washington, D.C. (May 31, 2019) – Today, the Biotechnology Innovation Organization (BIO) released the 2019 Emerging Therapeutic Company Trend Report, highlighting ten years (2009-2018) of biotechnology funding and deal making across five areas: venture capital, Initial Public Offerings (IPOs),…